Data Bridge Market Research analyses the market to account to USD 3,932.87 million by 2027 36
Artificial intelligence (AI) in drug discovery market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 3,932.87 million by 2027 growing at a CAGR of 40.5% in the above-mentioned forecast period. The growing awareness amongst the physicians and patients regarding the benefits of artificial intelligence has been directly impacting the growth of the market.
The major players covered in the artificial intelligence (AI) in drug discovery market report are
Microsoft, NVIDIA Corporation, IBM Corporation, Atomwise, Inc., DEEP GENOMICS, Cloud Pharmaceuticals, Inc., Insilico Medicine, BenevolentAI Ltd, Exscientia, Cyclica Inc., Numerate, NuMedii, Inc., Envisagenics., twoXAR, Incorporated, OWKIN, INC., XtalPi Inc., BERG LLC, among other domestic and global players.
Data Bridge Market Research recently added “
Global Artificial Intelligence (AI) in Drug Discovery Market by manufacturers, regions, type and application, forecast to 2028” in his database. This research report focus on complete assessment of market and contains future trend, growth factors, attentive opinions, facts, historical data, statistically supported and industry-validated market data. Environmental concerns & regulatory guidelines regarding release of effluents through different industries.
Global Artificial Intelligence (AI) in Drug Discovery Market comprehensive coverage of underlying economic and technological factors under key trend analysis.
Global Artificial Intelligence (AI) in Drug Discovery Market By Offering (Software, Services), Technology (Machine Learning, Other Technologies), Drug Type (Small Molecule, Large Molecules), Application (Immuno-Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Other Applications), End-User